UnitedHealth CEO steps down for ‘personal reasons’
Andrew Witty is stepping down from his position as CEO of UnitedHealth Group for personal reasons, with Stephen Hemsley taking over as his successor. Witty, who served as CEO for four years, will continue in a limited capacity as a senior adviser. During his tenure, he faced the aftermath of UnitedHealthcare CEO Brian Thompson's murder and addressed public criticism of the health insurance industry. The company has suspended its financial outlook for the year due to unexpectedly high Medicare Advantage costs, anticipating a return to growth by 2026. UnitedHealth's stock suffered a significant drop, falling over 20% after a disappointing earnings report last month.
Context:
Andrew Witty is stepping down from his position as CEO of UnitedHealth Group for personal reasons, with Stephen Hemsley taking over as his successor. Witty, who served as CEO for four years, will continue in a limited capacity as a senior adviser. During his tenure, he faced the aftermath of UnitedHealthcare CEO Brian Thompson's murder and addressed public criticism of the health insurance industry. The company has suspended its financial outlook for the year due to unexpectedly high Medicare Advantage costs, anticipating a return to growth by 2026. UnitedHealth's stock suffered a significant drop, falling over 20% after a disappointing earnings report last month.
Dive Deeper:
Andrew Witty has resigned as CEO of UnitedHealth Group, citing personal reasons, and will be succeeded by Stephen Hemsley, the company's board chairman and former CEO.
Witty, who will remain as a senior adviser, led the company during the challenging period following the murder of UnitedHealthcare CEO Brian Thompson, which led to heightened public scrutiny of the health insurance sector.
He publicly acknowledged the imperfections of the US health system and defended UnitedHealthcare while accepting some responsibility for the industry's misunderstood coverage decisions.
UnitedHealth Group has suspended its financial outlook for the current year due to higher-than-expected costs associated with Medicare Advantage, with expectations to resume growth by 2026.
Following a disappointing earnings report, UnitedHealth's stock experienced its largest single-day drop in nearly thirty years, with shares falling over 20% and continuing to decline in premarket trading.